IRD vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

IRD

39.4
AI Score
VS
IRD Wins

JBIO

32.9
AI Score

Investment Advisor Scores

IRD

39score
Recommendation
AVOID NEW MONEY

JBIO

33score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric IRD JBIO Winner
Forward P/E 12.0048 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -63.1% 0.0% JBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 39.4/100 32.9/100 IRD
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

IRD 1M: -1.7% · 3M: +9.0% JBIO 1M: +17.3% · 3M: -31.2%

Current Technical Phase

IRD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.2 · Price: $3.98

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.0 · Price: $16.14

Fundamentals Snapshot

Metric IRD JBIO
Market Cap — —
Forward P/E -5.3 -6.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.6% 0.0%
Gross Margin -4.9% —
Operating Margin -7.8% 0.0%
EPS -1.48 -1.92
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IRD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.